Recombinant Anti-NGF x Anti-TNF Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-NGF antibody variable domain is fused to the C terminal of an IgG of anti-TNF antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Osteoarthritis therapy.
There are currently no customer reviews or questions for Recombinant Anti-NGF x Anti-TNF Bispecific Antibody (IgG-Fv) (BSGV-182). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS